home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Formulation & Drug Delivery Congress

 
  December 01, 2014  
     
 
Oxford Global, London, UK
18-19 May 2015


 This senior level congress brings together over 150 experts to assess recent technological innovations and discuss their impact on product improvement and patient experience.

Day 1 Stream 1 – Optimising Formulation

  • Optimising formulation: improving stability and solubility
  • Advances in formulation using dissolution testing
  • Novel technologies: self-emulsifying technology, microformulations
  • Hot melt extrusion for enhanced solubility
  • Improving liquid, solid state formulation properties

Day 1 Stream 2 – Improving Drug Delivery

  • The increasing role of nanomedicine in drug delivery
  • Collaborative strategies to drug delivery challenges
  • Overcoming bioavailability & toxicology challenges
  • Drug delivery case studies: silk-based lyogels, gene delivery vehicles, self microemulsifying systems

Day 2 Stream 1 – Formulation and Drug Delivery Strategies

  • Optimising biologics formulation: improving quality and stability
  • Biopharma formulation and delivery
  • Novel formulation for NBEs delivery
  • New technology case studies: nanomaterials, HT methodologies
  • Formulation considerations for complex molecules

Day 2 Stream 2 – Product Development Considerations

  • User-focused product development: what do patients need from administration systems?
  • Implementing Quality by Design from pre-formulation through to commercial manufacture
  • Advanced development & design strategies
  • Technology and process transfer: form formulation research to successful product launch
  • Assessments for new chemical entities
 
 
Organized by: Oxford Global
Invited Speakers:

Jean Alie
Head of Solid State Characterization, Sanofi

Katie Amssoms
Principal Scientist, Janssen

Jon Beaman
Senior Director, Analytical Research and Development, Pfizer Ltd UK

Anne Bechet
Director Project Management, Prosensa 

Steve Brown
Executive Director, Pharmaceutical Technology, Actavis

 
Deadline for Abstracts: Please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk or call +44 (0)1865 248455
 
Registration: For more information about how to register please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk or phone +44 (0)1865 248455
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.